LEWIS, RUSSELL EDWARD

LEWIS, RUSSELL EDWARD  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 20 di 60 (tempo di esecuzione: 0.061 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
In vitro interactions of sulbactam/durlobactam in combination with meropenem, ceftazidime/avibactam, piperacillin/tazobactam, cefiderocol and fosfomycin against carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates 2026 Lewis R. E. + EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES - -
Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis 2025 Lewis R. E. + JOURNAL OF INFECTION - -
Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria 2025 Lewis R. E. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
Fungal infections in patients with haematological malignancies in the pre-triazole era: the dawn of a new era in medical mycology 2025 Lewis R. E. + CLINICAL MICROBIOLOGY AND INFECTION - -
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM 2025 Lewis, Russell E + THE LANCET INFECTIOUS DISEASES - -
Lights and Shadows of Essential Oil-Derived Compounds: Antimicrobial and Anti-Inflammatory Properties of Eugenol, Thymol, Cinnamaldehyde, and Carvacrol 2025 Lewis R. E. + CURRENT ISSUES IN MOLECULAR BIOLOGY - -
On the shoulders of a giant: an appraisal of the legacy of Dr. Gerald P Bodey to infectious diseases 2025 Lewis R. E. + CLINICAL MICROBIOLOGY AND INFECTION - -
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics 2025 Lewis R. E. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
The long walk to a short half-life: the discovery of augmented renal clearance and its impact on antibiotic dosing 2025 Lewis R. E. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
Identification and validation of diagnostic cutoffs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 2024 Lewis R. + PLOS ONE - -
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes 2024 Jiang Y.Lewis R. E. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good? 2024 Lewis R. E. + CLINICAL MICROBIOLOGY AND INFECTION - -
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria 2024 Lewis R. E. + CELLS - -
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research 2024 Lewis R. E. JOURNAL OF FUNGI - -
Triazole antifungal drug interactions - Practical considerations for excellent prescribing 2024 Lewis R.Bassetti M. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia 2023 Lewis, Russell E. + CURRENT FUNGAL INFECTION REPORTS - -
Preface - Issue Supplement 2023 Lewis R. + JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - -
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? 2023 Lewis, Russell E + CURRENT OPINION IN INFECTIOUS DISEASES - -
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity 2023 Lewis, Russell E + OPEN FORUM INFECTIOUS DISEASES - -
Systemic antifungal agents 2023 Lewis R. E. + - - Diagnosis and Treatment of Fungal Infections Third Edition 2023